D. E. Shaw & Co. Inc. Has $1.49 Million Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

D. E. Shaw & Co. Inc. lifted its stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 100.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 53,332 shares of the technology company's stock after acquiring an additional 26,661 shares during the period. D. E. Shaw & Co. Inc. owned 0.27% of Simulations Plus worth $1,487,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SLP. JPMorgan Chase & Co. lifted its position in Simulations Plus by 106.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock worth $1,517,000 after acquiring an additional 24,371 shares during the last quarter. Tributary Capital Management LLC grew its position in shares of Simulations Plus by 21.7% in the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company's stock valued at $11,047,000 after purchasing an additional 70,526 shares during the last quarter. Cook Wealth LLC increased its stake in shares of Simulations Plus by 19.1% in the fourth quarter. Cook Wealth LLC now owns 12,386 shares of the technology company's stock worth $345,000 after purchasing an additional 1,984 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Simulations Plus by 15.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company's stock worth $62,090,000 after purchasing an additional 290,414 shares during the last quarter. Finally, Stephens Inc. AR bought a new stake in Simulations Plus during the 4th quarter valued at approximately $905,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have commented on SLP shares. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. KeyCorp raised their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 16th. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $50.00.

Simulations Plus Trading Down 0.4%

SLP traded down $0.15 on Tuesday, hitting $32.90. 125,777 shares of the stock traded hands, compared to its average volume of 287,678. The business has a fifty day moving average price of $29.82 and a two-hundred day moving average price of $30.41. The firm has a market capitalization of $661.55 million, a PE ratio of 82.24 and a beta of 1.10. Simulations Plus, Inc. has a 52 week low of $23.01 and a 52 week high of $50.11.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million during the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. Simulations Plus's revenue was up 22.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.20 earnings per share. On average, equities research analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Insider Activity at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now owns 3,344,157 shares of the company's stock, valued at approximately $112,062,701.07. This represents a 0.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 19.40% of the stock is currently owned by insiders.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.